Price T Rowe Associates Inc. MD lifted its stake in shares of National Health Investors, Inc. (NYSE:NHI - Free Report) by 12.3% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 32,039 shares of the real estate investment trust's stock after buying an additional 3,520 shares during the period. Price T Rowe Associates Inc. MD owned approximately 0.07% of National Health Investors worth $2,221,000 at the end of the most recent quarter.
A number of other large investors have also recently made changes to their positions in the stock. Norges Bank purchased a new position in shares of National Health Investors during the fourth quarter worth $42,322,000. Marshall Wace LLP grew its position in National Health Investors by 161.6% during the 4th quarter. Marshall Wace LLP now owns 551,585 shares of the real estate investment trust's stock worth $38,225,000 after purchasing an additional 340,712 shares during the period. Centersquare Investment Management LLC raised its stake in shares of National Health Investors by 35.9% during the 4th quarter. Centersquare Investment Management LLC now owns 394,433 shares of the real estate investment trust's stock valued at $27,334,000 after buying an additional 104,186 shares during the last quarter. Vanguard Group Inc. lifted its holdings in shares of National Health Investors by 1.6% in the 4th quarter. Vanguard Group Inc. now owns 6,423,210 shares of the real estate investment trust's stock valued at $445,128,000 after buying an additional 102,012 shares during the period. Finally, Principal Financial Group Inc. lifted its holdings in shares of National Health Investors by 5.3% in the 4th quarter. Principal Financial Group Inc. now owns 1,648,499 shares of the real estate investment trust's stock valued at $114,242,000 after buying an additional 82,825 shares during the period. 62.51% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
Several research firms recently commented on NHI. Truist Financial raised their target price on National Health Investors from $70.00 to $76.00 and gave the stock a "hold" rating in a report on Wednesday, March 19th. Wedbush reaffirmed an "outperform" rating and set a $88.00 price objective on shares of National Health Investors in a research note on Monday, March 17th. Three analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to MarketBeat, the company has a consensus rating of "Hold" and an average price target of $85.50.
Check Out Our Latest Report on NHI
National Health Investors Price Performance
Shares of National Health Investors stock traded down $0.95 on Tuesday, hitting $74.61. The company's stock had a trading volume of 31,542 shares, compared to its average volume of 224,510. The company has a market capitalization of $3.48 billion, a price-to-earnings ratio of 25.64, a price-to-earnings-growth ratio of 4.42 and a beta of 0.78. National Health Investors, Inc. has a 1 year low of $63.91 and a 1 year high of $86.13. The company has a debt-to-equity ratio of 0.92, a quick ratio of 10.29 and a current ratio of 10.29. The firm has a fifty day moving average price of $74.15 and a 200-day moving average price of $72.74.
National Health Investors (NYSE:NHI - Get Free Report) last posted its quarterly earnings data on Monday, May 5th. The real estate investment trust reported $1.15 EPS for the quarter, beating analysts' consensus estimates of $1.13 by $0.02. The business had revenue of $68.87 million during the quarter, compared to analysts' expectations of $85.13 million. National Health Investors had a return on equity of 10.11% and a net margin of 38.53%. The business's revenue was up 9.6% compared to the same quarter last year. During the same period in the previous year, the business earned $1.10 earnings per share. As a group, sell-side analysts anticipate that National Health Investors, Inc. will post 4.41 earnings per share for the current fiscal year.
National Health Investors Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 1st. Shareholders of record on Monday, June 30th will be issued a dividend of $0.90 per share. This represents a $3.60 annualized dividend and a yield of 4.83%. The ex-dividend date is Monday, June 30th. National Health Investors's payout ratio is 114.29%.
National Health Investors Company Profile
(
Free Report)
Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
Further Reading
Before you consider National Health Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Health Investors wasn't on the list.
While National Health Investors currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
